ConductScience.org, home

Paper28483

Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.

Siber GR and 4 others. N Engl J Med, 1978. Cited by 221 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. Papers, record 28483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28483

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
PubMed
Journal
N Engl J Med
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
221
iCite
Relative citation ratio, by iCite
9.6
iCite
Revised in PubMed
2009-10-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Siber GRG R
2Weitzman SAS A
3Aisenberg ACA C
4Weinstein HJH J
5Schiffman GG

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, BacterialMajor topic
Bacterial VaccinesMajor topic
Hodgkin DiseaseMajor topic
Streptococcus pneumoniaeMajor topic
Adolescent
Adult
Antibody Formation
Child
Humans
Immunization
Middle Aged
Polysaccharides, Bacterial
Splenectomy
Time Factors

Source PubMed

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.

PMIDTitleJournalYearIn PapersSource
36,899,075Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers.Sci Rep2023https://conductscience.org/library/papers/36899075PubMed
35,081,732Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study.Future Oncol2022https://conductscience.org/library/papers/35081732PubMed
34,047,765Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.JAMA Oncol2021https://conductscience.org/library/papers/34047765PubMed
28,828,339The Immune Response of Vaccination Against Hepatitis B virus in Iranian Patients Undergoing Chemotherapy.Adv Biomed Res2017https://conductscience.org/library/papers/28828339PubMed
27,648,207Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety.Mediterr J Hematol Infect Dis2016https://conductscience.org/library/papers/27648207PubMed
11,100,283Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.Bone Marrow Transplant2000https://conductscience.org/library/papers/11100283PubMed
9,384,280Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.Clin Diagn Lab Immunol1997https://conductscience.org/library/papers/9384280PubMed
8,846,624Optimal delivery of vaccines: clinical pharmacokinetic considerations.Clin Pharmacokinet1996https://conductscience.org/library/papers/8846624PubMed
8,601,117Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen.BMJ1996https://conductscience.org/library/papers/8601117PubMed
8,432,585Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.Infect Immun1993https://conductscience.org/library/papers/8432585PubMed
7,883,209Hyposplenism in gastrointestinal disease.Gut1995https://conductscience.org/library/papers/7883209PubMed
7,399,682Graphical method for evaluating antibody response to vaccines.Infect Immun1980https://conductscience.org/library/papers/7399682PubMed
7,334,071Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hodgkin's lymphoma in remission.J Clin Immunol1981https://conductscience.org/library/papers/7334071PubMed
7,305,495The risk of sepsis in the asplenic adult.Ann Surg1981https://conductscience.org/library/papers/7305495PubMed
7,216,447Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.Infect Immun1981https://conductscience.org/library/papers/7216447PubMed
7,068,216Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers.Infect Immun1982https://conductscience.org/library/papers/7068216PubMed
7,015,698The overwhelming postsplenectomy sepsis problem.World J Surg1980https://conductscience.org/library/papers/7015698PubMed
6,996,624Response of renal allograft recipients to pneumococcal vaccine.Ann Surg1980https://conductscience.org/library/papers/6996624PubMed
6,616,391Overwhelming pneumococcal infection in a hyposplenic adult.Can Med Assoc J1983https://conductscience.org/library/papers/6616391PubMed
6,601,061Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.Infect Immun1983https://conductscience.org/library/papers/6601061PubMed

See all 35 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28483

GET https://conductscience.org/api/papers/v1/28483/cited_by?page=2